The Contraceptive Drugs And Devices Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The global market for contraceptive drugs and devices has experienced substantial growth recently. It is expected to increase from $25.30 billion in 2024 to $27.24 billion in 2025, with a compound annual growth rate (CAGR) of 7.7%.
The Contraceptive Drugs And Devices Global Market is expected to grow to a size of $36.31 billion in 2029, with a compound annual growth rate (CAGR) of 7.5%.
Download Your Free Sample of the 2025 Contraceptive Drugs And Devices Market Report and Uncover Key Trends Now!The key drivers in the contraceptive drugs and devices market are:
• Growing demand for long-acting reversible contraceptives
• Increasing focus on women's reproductive health
• Rising prevalence of sexually transmitted infections
• Expanding access to contraceptives via e-commerce and telehealth platforms
The contraceptive drugs and devices market covered in this report is segmented –
1) By Product: Contraceptive Drugs, Contraceptive Devices
2) By Technology: Traditional Methods, Digital Contraceptive Apps, Wearable Devices, Long-Acting Reversible Contraceptives (LARCs)
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channels And Non-Governmental Organizations, Other Distribution Channels
4) By End User: Male, Female
The key trends in the contraceptive drugs and devices market are:
• A rising trend is the development of smart contraceptive devices with digital tracking capabilities.
• There is a movement towards creating biodegradable implants and patches in the contraceptive industry.
• The market is seeing innovative changes with the introduction of hormone-free contraceptives.
• The use of AI-driven fertility monitoring apps is shaping the future of the contraceptive market.
Major players in the contraceptive drugs and devices market are:
• Pfizer Inc.
• Johnson & Johnson Services Inc.
• Merck & Co Inc.
• Bayer AG
• Viatris Inc.
• Teva Pharmaceuticals Ltd
• Lupin Limited
• CooperSurgical Inc.
• Mithra Pharmaceuticals
• DKT International
• Fuji Latex Co Ltd
• Agile Therapeutics Inc.
• Cupid Limited
• Veru Inc.
• Eskag Pharma Pvt. Ltd.
• Biosante Pharmaceuticals Inc.
• HLL Lifecare Limited
• Afaxys Inc.
• The Female Health Company (FC2)
• Mayer Laboratories Inc.
• Daré Bioscience Inc.
North America was the largest region in the contraceptive drugs and devices market in 2024